annual D&A:
$346.00K+$54.00K(+18.49%)Summary
- As of today (August 3, 2025), VKTX annual depreciation & amortization is $346.00 thousand, with the most recent change of +$54.00 thousand (+18.49%) on December 31, 2024.
- During the last 3 years, VKTX annual D&A has risen by +$50.00 thousand (+16.89%).
- VKTX annual D&A is now at all-time high.
Performance
VKTX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$112.00K+$1000.00(+0.90%)Summary
- As of today (August 3, 2025), VKTX quarterly depreciation & amortization is $112.00 thousand, with the most recent change of +$1000.00 (+0.90%) on June 30, 2025.
- Over the past year, VKTX quarterly D&A has increased by +$37.00 thousand (+49.33%).
- VKTX quarterly D&A is now -21.13% below its all-time high of $142.00 thousand, reached on September 30, 2022.
Performance
VKTX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$420.00K+$37.00K(+9.66%)Summary
- As of today (August 3, 2025), VKTX TTM depreciation & amortization is $420.00 thousand, with the most recent change of +$37.00 thousand (+9.66%) on June 30, 2025.
- Over the past year, VKTX TTM D&A has increased by +$124.00 thousand (+41.89%).
- VKTX TTM D&A is now at all-time high.
Performance
VKTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
VKTX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.5% | +49.3% | +41.9% |
| 3 y3 years | +16.9% | +100.0% | +84.2% |
| 5 y5 years | +33.1% | +64.7% | +56.7% |
VKTX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.9% | -21.1% | >+9999.0% | at high | +84.2% |
| 5 y | 5-year | at high | +33.1% | -21.1% | >+9999.0% | at high | +84.2% |
| alltime | all time | at high | >+9999.0% | -21.1% | >+9999.0% | at high | +556.3% |
VKTX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $112.00K(+0.9%) | $420.00K(+9.7%) |
| Mar 2025 | - | $111.00K(+0.9%) | $383.00K(+10.7%) |
| Dec 2024 | $346.00K(+18.5%) | $110.00K(+26.4%) | $346.00K(+11.6%) |
| Sep 2024 | - | $87.00K(+16.0%) | $310.00K(+4.7%) |
| Jun 2024 | - | $75.00K(+1.4%) | $296.00K(+0.7%) |
| Mar 2024 | - | $74.00K(0.0%) | $294.00K(+0.7%) |
| Dec 2023 | $292.00K(+0.3%) | $74.00K(+1.4%) | $292.00K(+0.7%) |
| Sep 2023 | - | $73.00K(0.0%) | $290.00K(-19.2%) |
| Jun 2023 | - | $73.00K(+1.4%) | $359.00K(+25.5%) |
| Mar 2023 | - | $72.00K(0.0%) | $286.00K(-1.7%) |
| Dec 2022 | $291.00K | $72.00K(-49.3%) | $291.00K(-1.4%) |
| Sep 2022 | - | $142.00K(>+9900.0%) | $295.00K(+29.4%) |
| Jun 2022 | - | $0.00(-100.0%) | $228.00K(-24.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $77.00K(+1.3%) | $301.00K(+1.7%) |
| Dec 2021 | $296.00K(+6.9%) | $76.00K(+1.3%) | $296.00K(+1.7%) |
| Sep 2021 | - | $75.00K(+2.7%) | $291.00K(+1.7%) |
| Jun 2021 | - | $73.00K(+1.4%) | $286.00K(+1.8%) |
| Mar 2021 | - | $72.00K(+1.4%) | $281.00K(+1.4%) |
| Dec 2020 | $277.00K(+6.5%) | $71.00K(+1.4%) | $277.00K(+1.8%) |
| Sep 2020 | - | $70.00K(+2.9%) | $272.00K(+1.5%) |
| Jun 2020 | - | $68.00K(0.0%) | $268.00K(+1.5%) |
| Mar 2020 | - | $68.00K(+3.0%) | $264.00K(+1.5%) |
| Dec 2019 | $260.00K(>+9900.0%) | $66.00K(0.0%) | $260.00K(+34.0%) |
| Sep 2019 | - | $66.00K(+3.1%) | $194.00K(+51.6%) |
| Jun 2019 | - | $64.00K(0.0%) | $128.00K(+100.0%) |
| Mar 2019 | - | $64.00K | $64.00K |
| Dec 2018 | $0.00 | - | - |
FAQ
- What is Viking Therapeutics, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. annual D&A year-on-year change?
- What is Viking Therapeutics, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Viking Therapeutics, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. TTM D&A year-on-year change?
What is Viking Therapeutics, Inc. annual depreciation & amortization?
The current annual D&A of VKTX is $346.00K
What is the all time high annual D&A for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high annual depreciation & amortization is $346.00K
What is Viking Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, VKTX annual depreciation & amortization has changed by +$54.00K (+18.49%)
What is Viking Therapeutics, Inc. quarterly depreciation & amortization?
The current quarterly D&A of VKTX is $112.00K
What is the all time high quarterly D&A for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high quarterly depreciation & amortization is $142.00K
What is Viking Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, VKTX quarterly depreciation & amortization has changed by +$37.00K (+49.33%)
What is Viking Therapeutics, Inc. TTM depreciation & amortization?
The current TTM D&A of VKTX is $420.00K
What is the all time high TTM D&A for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high TTM depreciation & amortization is $420.00K
What is Viking Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, VKTX TTM depreciation & amortization has changed by +$124.00K (+41.89%)